抗人uPA/PLAU(B chain)鼠单抗-抗体-抗体-生物在线
北京义翘神州科技有限公司
抗人uPA/PLAU(B chain)鼠单抗

抗人uPA/PLAU(B chain)鼠单抗

商家询价

产品名称: 抗人uPA/PLAU(B chain)鼠单抗

英文名称: uPA/PLAU uPA PLAU

产品编号: 10815-MM01

产品价格: null

产品产地: 北京

品牌商标: 义翘神州(SinoBiologi

更新时间: null

使用范围: western blot

北京义翘神州科技有限公司
  • 联系人 :
  • 地址 : 北京亦庄东区科创十街18号院9号楼306室
  • 邮编 : 100176
  • 所在区域 : 北京
  • 电话 : 点击查看
  • 传真 : 点击查看
  • 邮箱 : marketing@sinobiological.cn

官方网址:http://www.sinobiological.cn/Urokinase-PLAU-Antibody-g-1712.html

Urokinase-type Plasminogen Activator ( uPA / PLAU ) Antibody

  Order or Inquire for uPA Antibody product Antibody
  Detect B chain and full-length of uPA in WB
  Detection limit is 25 ng/lane in WB

uPA / PLAU抗体产品信息

免疫原 :

Recombinant human uPA protein ( Catalog#10815-H08H )

抗体类型: Mouse Monoclonal Antibody ( Mouse mAb Service Platform )

克隆号 :

2G11A6E10

抗体宿主 :

Mouse  IgG1

缓冲液 : 0.2 μm filtered solution in PBS with 5% trehalose
制备方法 :

This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, human cell-derived, recombinant human uPA / PLAU ( rhPLAU; Catalog#10815-H08H; Met 1-Leu 431; NP_002649.1). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.

uPA / PLAU抗体使用指南

特异性 :

Human uPA / PLAU

  No cross-reactivity with human cell lysate ( 293 cell line ) in WB and ELISA.
Western blot : This antibody can be used at 1 - 2 μg/mL with the appropriate secondary reagents to detect B chain and full-length of uPA in WB. Using a DAB  detection system, the detection limit for uPA is approximately 25 ng/lane under non-reducing conditions. Use of this antibody under reducing conditions is not recommended.
储存方法 : This antibody can be stored at 2℃-8℃ for 1 month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -70℃. Preservative-Free.
Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.

uPA / PLAU Antibody Related Products & Topics

相关研究领域:

Enzyme>>Protease & Regulator>>Serine Protease & Regulator>>Urokinase/PLAU/u-PA

Cancer>>Cancer Biomarkers>>Urokinase/PLAU/u-PA

Immunology>>Innate Immunity>>Coagulation>>Urokinase/PLAU/u-PA

蛋白:

Molecule Species Description //For Detailed Info.------CLICK! Cat No
Urokinase/PLAU/u-PA Human Urokinase/PLAU/u-PA Protein, Recombinant 10815-H08H

抗体:

Molecule Application Description //For Detailed Info.------CLICK! Cat No
Human Urokinase/PLAU/u-PA WB Mouse Monoclonal Antibody 10815-MM01
Human Urokinase/PLAU/u-PA WB Mouse Monoclonal Antibody 10815-MM02
Human Urokinase/PLAU/u-PA ELISA Mouse Monoclonal Antibody 10815-MM03

uPA / PLAU抗体背景综述

Plasminogen activator, urokinase, also known as PLAU and uPA, is a serine protease involved in degradation of the extracellular matrix and possibly tumor cell migration and proliferation. The human PLAU is initially synthesized as 431 amino acid precursor with a N-terminal signal peptide (20 residues). The single chain molecule is processed into a disulfide-linked two-chain molecule of different molecular weights. Two forms of the A chain exist, starting at Ser21 (the long form) and Lys156 (the short form). The long and short A chains are unique to the high and low molecular weight forms, respectively. The long A chain contains an EGF-like domain, responsible for binding of the PLAU receptor. The B chain corresponds to the catalytic domain. PLAU is a potent marker of invasion and metastasis in a variety of human cancers associated with breast, stomach, colon, bladder, ovary, brain and endometrium. A specific polymorphism in PLAU gene is implicated in late-onset Alzheimer disease and also with decreased affinity for fibrin-binding.

参考文献

  1. Nagai, M. et al., 1985, Gene. 36:183-8.
  2. Jacobs, P. et al., 1985, DNA. 4:139-46.
  3. Geiger, M. et al., 1989,  Blood. 74 (2): 722-8.
  4. Ploug, M. et al., 2002,  Biochem. Soc. Trans. 30 (2): 177-83. 
  5. Duffy, MJ., 2002, Biochem. Soc. Trans. 30: 207-10.
  6. Alfano, M. et al., 2004, J. Leukoc. Biol. 74 (5): 750-6.